COVID-19 Impact on Global Biliary Tract Disorder Treatment Market Size, Status and Forecast 2020-2026
- BMR3871642
- 95 Pages
- June 2020
- Healthcare
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biliary Tract Disorder Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biliary Tract Disorder Treatment industry.
Based on our recent survey, we have several different scenarios about the Biliary Tract Disorder Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biliary Tract Disorder Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biliary Tract Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biliary Tract Disorder Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Biliary Tract Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biliary Tract Disorder Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biliary Tract Disorder Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biliary Tract Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biliary Tract Disorder Treatment market.
The following players are covered in this report:
AstraZeneca
Asklepion Pharmaceuticals
Intuitive Surgical
Merck
Abbott Laboratories
Boston Scientific
Conmed
Cook Medical
B. Braun Melsungen
Medtronic
Terumo
Merit Medical
Olympus
Becton Dickinson
Biliary Tract Disorder Treatment Breakdown Data by Type
Mecine
Surgery
Other
Biliary Tract Disorder Treatment Breakdown Data by Application
Hospitals
Clinics
Other
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biliary Tract Disorder Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Biliary Tract Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Mecine
1.4.3 Surgery
1.4.4 Other
1.5 Market by Application
1.5.1 Global Biliary Tract Disorder Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Biliary Tract Disorder Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Biliary Tract Disorder Treatment Industry
1.6.1.1 Biliary Tract Disorder Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biliary Tract Disorder Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biliary Tract Disorder Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Biliary Tract Disorder Treatment Market Perspective (2015-2026)
2.2 Biliary Tract Disorder Treatment Growth Trends by Regions
2.2.1 Biliary Tract Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biliary Tract Disorder Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Biliary Tract Disorder Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biliary Tract Disorder Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Biliary Tract Disorder Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biliary Tract Disorder Treatment Players by Market Size
3.1.1 Global Top Biliary Tract Disorder Treatment Players by Revenue (2015-2020)
3.1.2 Global Biliary Tract Disorder Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Biliary Tract Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biliary Tract Disorder Treatment Market Concentration Ratio
3.2.1 Global Biliary Tract Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biliary Tract Disorder Treatment Revenue in 2019
3.3 Biliary Tract Disorder Treatment Key Players Head office and Area Served
3.4 Key Players Biliary Tract Disorder Treatment Product Solution and Service
3.5 Date of Enter into Biliary Tract Disorder Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Biliary Tract Disorder Treatment Historic Market Size by Type (2015-2020)
4.2 Global Biliary Tract Disorder Treatment Forecasted Market Size by Type (2021-2026)
5 Biliary Tract Disorder Treatment Breakdown Data by Application (2015-2026)
5.1 Global Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
5.2 Global Biliary Tract Disorder Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biliary Tract Disorder Treatment Market Size (2015-2020)
6.2 Biliary Tract Disorder Treatment Key Players in North America (2019-2020)
6.3 North America Biliary Tract Disorder Treatment Market Size by Type (2015-2020)
6.4 North America Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biliary Tract Disorder Treatment Market Size (2015-2020)
7.2 Biliary Tract Disorder Treatment Key Players in Europe (2019-2020)
7.3 Europe Biliary Tract Disorder Treatment Market Size by Type (2015-2020)
7.4 Europe Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
8 China
8.1 China Biliary Tract Disorder Treatment Market Size (2015-2020)
8.2 Biliary Tract Disorder Treatment Key Players in China (2019-2020)
8.3 China Biliary Tract Disorder Treatment Market Size by Type (2015-2020)
8.4 China Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biliary Tract Disorder Treatment Market Size (2015-2020)
9.2 Biliary Tract Disorder Treatment Key Players in Japan (2019-2020)
9.3 Japan Biliary Tract Disorder Treatment Market Size by Type (2015-2020)
9.4 Japan Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biliary Tract Disorder Treatment Market Size (2015-2020)
10.2 Biliary Tract Disorder Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biliary Tract Disorder Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
11 India
11.1 India Biliary Tract Disorder Treatment Market Size (2015-2020)
11.2 Biliary Tract Disorder Treatment Key Players in India (2019-2020)
11.3 India Biliary Tract Disorder Treatment Market Size by Type (2015-2020)
11.4 India Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biliary Tract Disorder Treatment Market Size (2015-2020)
12.2 Biliary Tract Disorder Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Biliary Tract Disorder Treatment Market Size by Type (2015-2020)
12.4 Central & South America Biliary Tract Disorder Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview and Its Total Revenue
13.1.3 AstraZeneca Biliary Tract Disorder Treatment Introduction
13.1.4 AstraZeneca Revenue in Biliary Tract Disorder Treatment Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Asklepion Pharmaceuticals
13.2.1 Asklepion Pharmaceuticals Company Details
13.2.2 Asklepion Pharmaceuticals Business Overview and Its Total Revenue
13.2.3 Asklepion Pharmaceuticals Biliary Tract Disorder Treatment Introduction
13.2.4 Asklepion Pharmaceuticals Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.2.5 Asklepion Pharmaceuticals Recent Development
13.3 Intuitive Surgical
13.3.1 Intuitive Surgical Company Details
13.3.2 Intuitive Surgical Business Overview and Its Total Revenue
13.3.3 Intuitive Surgical Biliary Tract Disorder Treatment Introduction
13.3.4 Intuitive Surgical Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.3.5 Intuitive Surgical Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Biliary Tract Disorder Treatment Introduction
13.4.4 Merck Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Details
13.5.2 Abbott Laboratories Business Overview and Its Total Revenue
13.5.3 Abbott Laboratories Biliary Tract Disorder Treatment Introduction
13.5.4 Abbott Laboratories Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.5.5 Abbott Laboratories Recent Development
13.6 Boston Scientific
13.6.1 Boston Scientific Company Details
13.6.2 Boston Scientific Business Overview and Its Total Revenue
13.6.3 Boston Scientific Biliary Tract Disorder Treatment Introduction
13.6.4 Boston Scientific Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.6.5 Boston Scientific Recent Development
13.7 Conmed
13.7.1 Conmed Company Details
13.7.2 Conmed Business Overview and Its Total Revenue
13.7.3 Conmed Biliary Tract Disorder Treatment Introduction
13.7.4 Conmed Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.7.5 Conmed Recent Development
13.8 Cook Medical
13.8.1 Cook Medical Company Details
13.8.2 Cook Medical Business Overview and Its Total Revenue
13.8.3 Cook Medical Biliary Tract Disorder Treatment Introduction
13.8.4 Cook Medical Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.8.5 Cook Medical Recent Development
13.9 B. Braun Melsungen
13.9.1 B. Braun Melsungen Company Details
13.9.2 B. Braun Melsungen Business Overview and Its Total Revenue
13.9.3 B. Braun Melsungen Biliary Tract Disorder Treatment Introduction
13.9.4 B. Braun Melsungen Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.9.5 B. Braun Melsungen Recent Development
13.10 Medtronic
13.10.1 Medtronic Company Details
13.10.2 Medtronic Business Overview and Its Total Revenue
13.10.3 Medtronic Biliary Tract Disorder Treatment Introduction
13.10.4 Medtronic Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
13.10.5 Medtronic Recent Development
13.11 Terumo
10.11.1 Terumo Company Details
10.11.2 Terumo Business Overview and Its Total Revenue
10.11.3 Terumo Biliary Tract Disorder Treatment Introduction
10.11.4 Terumo Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
10.11.5 Terumo Recent Development
13.12 Merit Medical
10.12.1 Merit Medical Company Details
10.12.2 Merit Medical Business Overview and Its Total Revenue
10.12.3 Merit Medical Biliary Tract Disorder Treatment Introduction
10.12.4 Merit Medical Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
10.12.5 Merit Medical Recent Development
13.13 Olympus
10.13.1 Olympus Company Details
10.13.2 Olympus Business Overview and Its Total Revenue
10.13.3 Olympus Biliary Tract Disorder Treatment Introduction
10.13.4 Olympus Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
10.13.5 Olympus Recent Development
13.14 Becton Dickinson
10.14.1 Becton Dickinson Company Details
10.14.2 Becton Dickinson Business Overview and Its Total Revenue
10.14.3 Becton Dickinson Biliary Tract Disorder Treatment Introduction
10.14.4 Becton Dickinson Revenue in Biliary Tract Disorder Treatment Business (2015-2020)
10.14.5 Becton Dickinson Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Biliary Tract Disorder Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Biliary Tract Disorder Treatment Revenue
Table 3. Ranking of Global Top Biliary Tract Disorder Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biliary Tract Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Mecine
Table 6. Key Players of Surgery
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Biliary Tract Disorder Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Biliary Tract Disorder Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Biliary Tract Disorder Treatment Players to Combat Covid-19 Impact
Table 13. Global Biliary Tract Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Biliary Tract Disorder Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Biliary Tract Disorder Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Biliary Tract Disorder Treatment Market Share by Regions (2015-2020)
Table 17. Global Biliary Tract Disorder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Biliary Tract Disorder Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Biliary Tract Disorder Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Biliary Tract Disorder Treatment Players
Table 24. Global Biliary Tract Disorder Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Biliary Tract Disorder Treatment Market Share by Players (2015-2020)
Table 26. Global Top Biliary Tract Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tract Disorder Treatment as of 2019)
Table 27. Global Biliary Tract Disorder Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Biliary Tract Disorder Treatment Product Solution and Service
Table 30. Date of Enter into Biliary Tract Disorder Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Biliary Tract Disorder Treatment Market Size Share by Type (2015-2020)
Table 34. Global Biliary Tract Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Biliary Tract Disorder Treatment Market Size Share by Application (2015-2020)
Table 36. Global Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Biliary Tract Disorder Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Biliary Tract Disorder Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Biliary Tract Disorder Treatment Market Share (2019-2020)
Table 40. North America Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Biliary Tract Disorder Treatment Market Share by Type (2015-2020)
Table 42. North America Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Biliary Tract Disorder Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Biliary Tract Disorder Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Biliary Tract Disorder Treatment Market Share (2019-2020)
Table 46. Europe Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Biliary Tract Disorder Treatment Market Share by Type (2015-2020)
Table 48. Europe Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Biliary Tract Disorder Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Biliary Tract Disorder Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Biliary Tract Disorder Treatment Market Share (2019-2020)
Table 52. China Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Biliary Tract Disorder Treatment Market Share by Type (2015-2020)
Table 54. China Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Biliary Tract Disorder Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Biliary Tract Disorder Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Biliary Tract Disorder Treatment Market Share (2019-2020)
Table 58. Japan Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Biliary Tract Disorder Treatment Market Share by Type (2015-2020)
Table 60. Japan Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Biliary Tract Disorder Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Biliary Tract Disorder Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Biliary Tract Disorder Treatment Market Share (2019-2020)
Table 64. Southeast Asia Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Biliary Tract Disorder Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Biliary Tract Disorder Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Biliary Tract Disorder Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Biliary Tract Disorder Treatment Market Share (2019-2020)
Table 70. India Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Biliary Tract Disorder Treatment Market Share by Type (2015-2020)
Table 72. India Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Biliary Tract Disorder Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Biliary Tract Disorder Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Biliary Tract Disorder Treatment Market Share (2019-2020)
Table 76. Central & South America Biliary Tract Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Biliary Tract Disorder Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Biliary Tract Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Biliary Tract Disorder Treatment Market Share by Application (2015-2020)
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Product
Table 83. AstraZeneca Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 84. AstraZeneca Recent Development
Table 85. Asklepion Pharmaceuticals Company Details
Table 86. Asklepion Pharmaceuticals Business Overview
Table 87. Asklepion Pharmaceuticals Product
Table 88. Asklepion Pharmaceuticals Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 89. Asklepion Pharmaceuticals Recent Development
Table 90. Intuitive Surgical Company Details
Table 91. Intuitive Surgical Business Overview
Table 92. Intuitive Surgical Product
Table 93. Intuitive Surgical Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 94. Intuitive Surgical Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Product
Table 98. Merck Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 99. Merck Recent Development
Table 100. Abbott Laboratories Company Details
Table 101. Abbott Laboratories Business Overview
Table 102. Abbott Laboratories Product
Table 103. Abbott Laboratories Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 104. Abbott Laboratories Recent Development
Table 105. Boston Scientific Company Details
Table 106. Boston Scientific Business Overview
Table 107. Boston Scientific Product
Table 108. Boston Scientific Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 109. Boston Scientific Recent Development
Table 110. Conmed Company Details
Table 111. Conmed Business Overview
Table 112. Conmed Product
Table 113. Conmed Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 114. Conmed Recent Development
Table 115. Cook Medical Business Overview
Table 116. Cook Medical Product
Table 117. Cook Medical Company Details
Table 118. Cook Medical Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 119. Cook Medical Recent Development
Table 120. B. Braun Melsungen Company Details
Table 121. B. Braun Melsungen Business Overview
Table 122. B. Braun Melsungen Product
Table 123. B. Braun Melsungen Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 124. B. Braun Melsungen Recent Development
Table 125. Medtronic Company Details
Table 126. Medtronic Business Overview
Table 127. Medtronic Product
Table 128. Medtronic Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 129. Medtronic Recent Development
Table 130. Terumo Company Details
Table 131. Terumo Business Overview
Table 132. Terumo Product
Table 133. Terumo Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 134. Terumo Recent Development
Table 135. Merit Medical Company Details
Table 136. Merit Medical Business Overview
Table 137. Merit Medical Product
Table 138. Merit Medical Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 139. Merit Medical Recent Development
Table 140. Olympus Company Details
Table 141. Olympus Business Overview
Table 142. Olympus Product
Table 143. Olympus Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 144. Olympus Recent Development
Table 145. Becton Dickinson Company Details
Table 146. Becton Dickinson Business Overview
Table 147. Becton Dickinson Product
Table 148. Becton Dickinson Revenue in Biliary Tract Disorder Treatment Business (2015-2020) (Million US$)
Table 149. Becton Dickinson Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tract Disorder Treatment Market Share by Type: 2020 VS 2026
Figure 2. Mecine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Biliary Tract Disorder Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Biliary Tract Disorder Treatment Report Years Considered
Figure 10. Global Biliary Tract Disorder Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biliary Tract Disorder Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Biliary Tract Disorder Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biliary Tract Disorder Treatment Market Share by Players in 2019
Figure 15. Global Top Biliary Tract Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tract Disorder Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biliary Tract Disorder Treatment Revenue in 2019
Figure 17. North America Biliary Tract Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biliary Tract Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biliary Tract Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biliary Tract Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biliary Tract Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biliary Tract Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biliary Tract Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. AstraZeneca Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 26. Asklepion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Asklepion Pharmaceuticals Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 28. Intuitive Surgical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Intuitive Surgical Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 32. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abbott Laboratories Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 34. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Boston Scientific Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 36. Conmed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Conmed Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 38. Cook Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Cook Medical Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 40. B. Braun Melsungen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. B. Braun Melsungen Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 42. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Medtronic Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 44. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Terumo Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 46. Merit Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Merit Medical Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 48. Olympus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Olympus Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 50. Becton Dickinson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Becton Dickinson Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
